United Therapeutics’ wholly-owned subsidiary Medicomp, Inc. manufactures and markets a variety of telecardiology services approved for health care reimbursement for patients with an array of possible cardiac arrhythmias. Our newest heart monitor, the CardioPAL SAVI, was recently approved by the United States Food and Drug Administration as the first ambulatory device to detect the p-wave, a diminutive but critical portion of the ECG that represents atrial activity.

Our CardioPAL® product is the most technologically advanced portable heart monitor in the industry.  Our EpiCardia® service provides cardiologists with a printed ECG report on their patients anywhere in the United States as quickly as one hour after the patient connects our device to a telephone receiver.  Finally, we are also providing pacemaker monitoring services.

Cardiac monitors are small portable devices taken home by patients to check for irregular heart rhythms over a period of days or weeks.  United Therapeutics offers doctors the smallest such monitors in the industry equipped with a software algorithm that can recognize 39 different kinds of arrhythmia.  Ultimately this technology could be used by millions of healthy people as a consumer-driven desire to monitor their heart’s performance on an ongoing basis.

Our telemedicine technology is so advanced, and convenient to use, that it was selected for installation on the International Space Station for cardiac monitoring of the astronauts. We previously established an excellent record for quality as the cardiac monitor for the Mir Space Station and potentially saved the life of Cosmonaut Commander Tsibliev by detecting an arrhythmia.   

In the coming years, telemedicine may become a natural part of our lives, with medical problems being detected and diagnosed before we are even aware of them.  Our cardiac monitors are on a development path to becoming so intelligent, lightweight and convenient that they could be worn by millions of people on a daily basis.  Since earlier treatment is almost always better than later treatment, we hope our telemedicine capability will play an important role in saving many lives.

To learn more about Medicomp, please click here.